blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2288401

EP2288401 - DOSE COUNTER AND LOCKOUT MECHANISM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.05.2019
Database last updated on 21.09.2024
FormerThe patent has been granted
Status updated on  08.06.2018
FormerGrant of patent is intended
Status updated on  07.03.2018
FormerExamination is in progress
Status updated on  11.08.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Map Pharmaceuticals Inc.
2525 Dupont Drive
Irvine, California 92612 / US
[2015/16]
Former [2011/09]For all designated states
MAP Pharmaceuticals Inc
2400 Bayshore Parkway, Suite 200
Mountain View, CA 94043 / US
Inventor(s)01 / SUGIANTO, Alfred
230 Constitution Drive
Menlo Park, CA 94025 / US
 [2011/09]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2018/28]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2011/09]Price, Nigel John King
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date09743076.307.05.2009
[2011/09]
WO2009US02860
Priority number, dateUS20080126855P07.05.2008         Original published format: US 126855 P
[2011/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009137089
Date:12.11.2009
Language:EN
[2009/46]
Type: A1 Application with search report 
No.:EP2288401
Date:02.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 12.11.2009 takes the place of the publication of the European patent application.
[2011/09]
Type: B1 Patent specification 
No.:EP2288401
Date:11.07.2018
Language:EN
[2018/28]
Search report(s)International search report - published on:US12.11.2009
(Supplementary) European search report - dispatched on:EP04.12.2014
ClassificationIPC:A61M15/00
[2011/09]
CPC:
A61M15/0081 (EP,US); A61M15/0026 (EP,US); A61M15/0076 (EP,US);
A61M15/009 (EP,US); A61M15/0091 (EP,US); A61M15/0096 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/28]
Former [2011/09]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:DOSISZÄHLER UND SPERRMECHANISMUS[2011/09]
English:DOSE COUNTER AND LOCKOUT MECHANISM[2011/09]
French:COMPTEUR DE DOSES ET MÉCANISME DE VERROUILLAGE[2011/09]
Entry into regional phase06.12.2010National basic fee paid 
06.12.2010Search fee paid 
06.12.2010Designation fee(s) paid 
06.12.2010Examination fee paid 
Examination procedure06.12.2010Examination requested  [2011/09]
26.06.2015Amendment by applicant (claims and/or description)
16.08.2017Despatch of a communication from the examining division (Time limit: M04)
28.11.2017Reply to a communication from the examining division
08.03.2018Communication of intention to grant the patent
25.05.2018Fee for grant paid
25.05.2018Fee for publishing/printing paid
25.05.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.08.2017
Opposition(s)12.04.2019No opposition filed within time limit [2019/25]
Fees paidRenewal fee
11.05.2011Renewal fee patent year 03
25.05.2012Renewal fee patent year 04
28.05.2013Renewal fee patent year 05
27.05.2014Renewal fee patent year 06
27.05.2015Renewal fee patent year 07
27.05.2016Renewal fee patent year 08
30.05.2017Renewal fee patent year 09
29.05.2018Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.05.2009
AT11.07.2018
CY11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
MK11.07.2018
MT11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
PT11.11.2018
[2022/31]
Former [2021/34]HU07.05.2009
AT11.07.2018
CY11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
MT11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
PT11.11.2018
Former [2021/32]HU07.05.2009
AT11.07.2018
CY11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
PT11.11.2018
Former [2021/26]AT11.07.2018
CY11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
PT11.11.2018
Former [2020/29]AT11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
PT11.11.2018
Former [2020/07]AT11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/37]AT11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
PL11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/24]AT11.07.2018
CZ11.07.2018
EE11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
PL11.07.2018
RO11.07.2018
SK11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/22]AT11.07.2018
CZ11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
PL11.07.2018
RO11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/12]AT11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
PL11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/11]AT11.07.2018
FI11.07.2018
HR11.07.2018
LT11.07.2018
PL11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/10]AT11.07.2018
FI11.07.2018
LT11.07.2018
PL11.07.2018
BG11.10.2018
NO11.10.2018
GR12.10.2018
IS11.11.2018
Former [2019/08]FI11.07.2018
LT11.07.2018
NO11.10.2018
IS11.11.2018
Former [2019/07]LT11.07.2018
Documents cited:Search[A]EP0414536  (RIKER LABORATORIES INC [US]) [A] 1-11 * the whole document *;
 [A]US2002078950  (O'LEARY DAVID [GB]) [A] 1-11 * the whole document *;
 [A]US2002100472  (CASPER ROBERT A [US], et al) [A] 1-11 * the whole document *;
 [A]EP1616592  (SOFOTEC GMBH & CO KG [DE]) [A] 1-11* the whole document *;
 [Y]US2006231093  (BURGE SIMON [GB], et al) [Y] 1-11 * abstract * * paragraphs [0066] - [0068] - [0 93] - [0098] - [ 102] - [0104] - [ 111] - [0114] *;
 [A]US2006283444  (JONES MATTHEW [GB], et al) [A] 1-11 * the whole document *;
 [Y]US2007062518  (GESER JOHANNES [DE], et al) [Y] 1-11 * abstract * * paragraphs [0066] - [0068] *
International search[A]US2002078950  (O'LEARY DAVID [GB]);
 [X]US2006231093  (BURGE SIMON [GB], et al);
 [Y]US2007062518  (GESER JOHANNES [DE], et al)
by applicantUS2006231093
 US2007062518
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.